PROF. ANTONIO TROVATO - CURRICULUM VITAE\n\nEDUCATION\n\nBorn in Rovigo (Italy), February 2, 1972: married\nDegree in Physics “cum laude”, University of Padua, July 1996.\nPhD in Condensed Matter Theory “cum laude”, SISSA (Trieste), October 2000.\n\nSINCE 2014: Associate Professor in Condensed Matter Theory, University of Padua.\n\nPREVIOUS POSITIONS:\n\n2000-2002 PostDoc, Niels Bohr Institute, Copenhagen.\n2002-2004 PostDoc, INFM, Padua Unit.\n2004-2006 PostDoc, University of Padua.\n2006-2008 Researcher (non permanent) CNISM, Padua Unit.\n2008-2014 Researcher (permanent), University of Padua.\n\nOTHER STAYS ABROAD AND DISTINCTIONS:\n\nFebruary 2003 Visiting scientist at SISSA (Trieste).\nSeptember 2004 and January 2005 Visiting scientist at EPFL (Lausanne).\n2017-2023 National Scientific Habilitation for Full Professorship in Condensed Matter Theory and in\nApplied Physics.\n\nRESEARCH TOPICS\n\nProtein folding and aggregation.\nStatistical mechanics of polymers and of disordered systems.\nOptimization algorithms.\nPhase transitions and Efimov effect in DNA physics.\nQuorum sensing in bacterial communication.\n\nSHORT SUMMARY OF SCIENTIFIC ACTIVITY\n\n58 PUBLICATIONS on peer reviewed scientific journals, total citations: 1450, H-index: 18 (ISI)\n18 INVITED TALKS; 3 LECTURES in International Summer Schools.\nSUPERVISOR of 2 PostDocs, 4 Ph.D., 12 master thesis, 21 bachelor thesis.\n\nCO-ORGANIZER OF CONFERENCES AND SEMINARS\n\n"Protein Physics: Structure, Dynamics, and Function, III”, Bressanone (Italy), February 6-8, 2014.\n“Living Systems: from interaction patterns to critical behaviour”, San Servolo - Venezia (Italy),\nSeptember 16-19, 2015.\n“Structure, Dynamics, and Function of Biomolecules, IV”, Bressanone (Italy), February 3-6t, 2016.\n“Structure, Dynamics, and Function of Biomolecules, V”, Bressanone (Italy), February 7-10, 2018.\n\nPATENTS AND TECHNOLOGY TRANSFER\n\nThe commercial license to use the software called PASTA, that I contributed to develop for predicting aggregation propensities of proteins, was sold by Padua University in 2012 to Bohringer Ingelheim and in 2015 to MedImmune.

Notices